Provided by Tiger Fintech (Singapore) Pte. Ltd.

Summit Therapeutics PLC

24.50
+0.39001.62%
Volume:1.18M
Turnover:28.34M
Market Cap:18.07B
PE:-79.03
High:24.53
Open:23.70
Low:23.55
Close:24.11
Loading ...

Summit Therapeutics Raised to Buy From Neutral by Citigroup

Dow Jones
·
26 Mar

S&P 500 Futures Decline In Premarket Trading; GameStop, Summit Therapeutics Lead

Dow Jones
·
26 Mar

Summit Therapeutics Shares up 4% Premarket After Citigroup Ugrades to Buy From Neutral, Raises PT to $35 From $23

THOMSON REUTERS
·
26 Mar

Summit Therapeutics Inc : Citigroup Raises to Buy From Neutral; Raises Target Price to $35 From $23

THOMSON REUTERS
·
26 Mar

Citigroup Upgrades Summit Therapeutics to Buy From Neutral, Adjusts Price Target to $35 From $23

MT Newswires Live
·
26 Mar

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
22 Mar

Summit Therapeutics Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
21 Mar

Cantor Fitzgerald Initiates Summit Therapeutics at Overweight

MT Newswires Live
·
21 Mar

Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday

MT Newswires Live
·
18 Mar

Summit Therapeutics names Robert LaCaze as Chief Commercial Officer

TIPRANKS
·
18 Mar

Is Summit Therapeutics Inc. (SMMT) the Best Multibagger Stock to Buy in 2025?

Insider Monkey
·
14 Mar

Stifel Nicolaus Keeps Their Buy Rating on Summit Therapeutics (SMMT)

TIPRANKS
·
11 Mar

Summit Therapeutics Inc. (SMMT): Why Are Analysts Bullish On This Hot Growth Stock Right Now?

Insider Monkey
·
09 Mar

U.K. New Car Sales Fell in February for Fifth Consecutive Month, SMMT Says

Dow Jones
·
05 Mar

Stock Track | Summit Therapeutics Soars 5.14% as Goldman Initiates Coverage with Buy Rating on Promising Drug

Stock Track
·
28 Feb

Merck Slips 8% in a Month: Should You Buy, Hold or Sell the Stock?

Zacks
·
28 Feb

Summit Therapeutics Initiated at Buy by Goldman Sachs

Dow Jones
·
28 Feb

Goldman starts Summit Therapeutics with a Buy on ivonescimab potential

TIPRANKS
·
28 Feb

Summit Therapeutics Inc. (SMMT): Among the Stocks That Will Go to the Moon According to Analysts

Insider Monkey
·
28 Feb

Why Summit Therapeutics Inc. (SMMT) Went Down On Monday?

Insider Monkey
·
26 Feb